Insider · CIK 0001883270
Raul R. Silva
Files at CING (Cingulate Inc.). First filing -, latest -.
In brief
Raul R. Silva files SEC Form 4 as officer at CING (Cingulate Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Raul R. Silva has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +4,293 | $0.00 | $0 | 4,293 | 12 d ago |
| Jul 16, 2026 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +53,600 | $0.00 | $0 | 53,600 | Jul 20, 2026 |
| Jul 16, 2026 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +26,400 | $0.00 | $0 | 26,400 | Jul 20, 2026 |
| Jun 30, 2026 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +3,885 | $0.00 | $0 | 3,885 | Jul 2, 2026 |
| Mar 31, 2026 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +3,422 | $0.00 | $0 | 3 | May 8, 2026 |
| Mar 9, 2026 | CING Cingulate Inc. | AGrant or award Common Stock | +4,526 | $0.00 | $0 | 6,473 | Mar 11, 2026 |
| Mar 9, 2026 | CING Cingulate Inc. | FTax withholding Common Stock | -1,828 | $0.00 | $0 | 4,645 | Mar 11, 2026 |
| Dec 31, 2025 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +6,625 | $0.00 | $0 | 6,625 | Jan 5, 2026 |
| Sep 30, 2025 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +7,334 | $0.00 | $0 | 7,334 | Nov 10, 2025 |
| Jul 7, 2025 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +51,500 | $0.00 | $0 | 51,500 | Jul 9, 2025 |
| Mar 31, 2025 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +1,000 | $0.00 | $0 | 1,000 | Jul 1, 2025 |
| Jun 30, 2025 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +1,000 | $0.00 | $0 | 1,000 | Jul 1, 2025 |
| Feb 18, 2025 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +17,630 | $0.00 | $0 | 17,630 | Feb 20, 2025 |
| Jan 17, 2025 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +2,748 | $0.00 | $0 | 2,748 | Jan 22, 2025 |
| Dec 31, 2024 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +1,000 | $0.00 | $0 | 1,000 | Jan 7, 2025 |
| Jun 11, 2024 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +63,324 | $0.00 | $0 | 63,324 | Jun 13, 2024 |
| Mar 29, 2024 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +1,000 | $0.00 | $0 | 1,000 | Apr 1, 2024 |
| Mar 4, 2024 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +16,676 | $0.00 | $0 | 16,676 | Mar 6, 2024 |
| Dec 29, 2023 | CING Cingulate Inc. | AGrant or award Stock Option (right to Buy)derivative | +1,000 | $0.00 | $0 | 1,000 | Jan 2, 2024 |
Questions about Raul R. Silva
Answered from the filings on this page, as of the latest one.
Is Raul R. Silva buying or selling?
Raul R. Silva has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Raul R. Silva's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Raul R. Silva has 0.
Where does Raul R. Silva file Form 4?
Raul R. Silva has filed Form 4 at CING (Cingulate Inc.) as EVP and CSO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.